Ophthalmic Formulations: Equivalence and Patient Care

Show Description +

Robert Noecker, MD, provides an overview of ophthalmic formulations and the affect on patient care. Subjects discussed included; the pros and cons of generic medications versus brand-name formulations, the importance of patients' adherence to prescribed glaucoma therapy in medical outcome, the key barriers to patients' adherence to prescribed glaucoma medical therapy, and effective strategies to ensure that patients receive the medications prescribed and facilitate their appropriate long-term use.
Free CME - To earn up to 2 AMA PRA Category 1 credits, click here.

Posted: 8/23/2010

Ophthalmic Formulations: Equivalence and Patient Care

Robert Noecker, MD, provides an overview of ophthalmic formulations and the affect on patient care. Subjects discussed included; the pros and cons of generic medications versus brand-name formulations, the importance of patients' adherence to prescribed glaucoma therapy in medical outcome, the key barriers to patients' adherence to prescribed glaucoma medical therapy, and effective strategies to ensure that patients receive the medications prescribed and facilitate their appropriate long-term use.
Free CME - To earn up to 2 AMA PRA Category 1 credits, click here.

Posted: 8/23/2010

Please log in to leave a comment.

More in Glaucoma

Building Trust and Managing Patient Expectations With iDose TR

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Case Presentation: A Straightforward iDose TR Exchange

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

Case Presentation: Navigating iDose TR Retreatment in a Patient Four Years Later

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA

An Interview With an iDose TR Retreatment Patient

I. Paul Singh, MD; Christine M. Funke, MD; Arkadiy Yadgarov, MD; and Savak “Sev” Teymoorian, MD, MBA